bioRxivMolecular BiologyPreprint
Structure-guided targeting of the GATAD2A-CHD4 interaction within the MBD2-NuRD complex results in high levels of HbF in adult erythroid cells
Shengzhe ShangiD, Sangam Giri GoswamiiD, Torry Li, Wang HeiD, Christopher R. TravisiD, Mikhail G. DozmoroviD, David C. WilliamsiD, Gordon D. GinderiD
Abstract
Fetal hemoglobin (HbF) expression is silenced postnatally in adult erythroid cells. Sufficiently increased expression of HbF has been shown to overcome the pathophysiologic sequelae of both sickle cell disease and beta-thalassemia. As the MBD2a-NuRD chromatin remodeling complex is required for silencing of HbF, the present studies were aimed at exploring a potential therapeutic approach for disrupting this complex. AlphaFold 3 and a recent crystal structure were employed to predict the critical interaction domains linking GATAD2A in the histone deacetylase core subcomplex (HDCC) of NuRD and the CHD4 ATPase which has been shown to be required for silencing of the fetal gamma-globin (HBG) genes. The two predicted critical domains, the CR2 helical domain of GATAD2A and the C-terminal domains 1 and 2 (C1b and C2ab) of CHD4, were validated by in vitro biophysical studies. Mutation of two amino acids in the CR2 helical domain of the endogenous GATAD2A gene in HUDEP-2 cells resulted in dissociation of CHD4, loss of repressive chromatin over the HBG promoter and ~40% HbF levels compared to < 1% in control cells. Strikingly, enforced expression of a peptide containing the helical portion of the CR2 domain of GATAD2A in both HUDEP-2 cells and primary adult erythroid cells resulted in high levels of HbF, with up to ~75% HbF compared to mutant peptide control level of ~9% in the latter without perturbing erythroid differentiation. These results suggest that targeting the critical interaction domains of GATAD2A and CHD4 with a macrocyclic peptide or small molecule may lead to much needed small molecule therapeutics for sickle cell disease. Key PointsAssociation of CHD4 with the HDCC core of the MBD2-NuRD chromatin remodeling complex is required for silencing of HbF expression in adult human erythroid cells Genetic alteration or enforced peptide expression of a critical helical domain of GATAD2A results in dissociation of CHD4 from the MBD2-NuRD complex and high-level expression of HbF.
- organism: human
- assay: proteomics
- research focus: drug response / drug discovery
- approach: experimental assay
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Macrocycle screening against the C-terminal region of CHD4 uncovers its role as an interaction hub in the formation of the nucleosome remodeling and deacetylase complex
David C. Williams, Jie Ren, … Albert A. Bowers·bioRxiv·Jun 7, 2026
- MLL1 complex is a critical regulator of fetal hemoglobin repression
Yufen Han, Bjorg Gudmundsdottir, … Yang Du·bioRxiv·Mar 24, 2025
- Dissecting polycomb complexes for enhanced fetal hemoglobin production
Paul J. Kaminski, Kristen Min, … Gerd A. Blobel·BloodPeer-reviewed·May 29, 2026
- ZNF410 represses fetal globin by devoted control of CHD4/NuRD
Divya S. Vinjamur, Qiuming Yao, … Daniel E. Bauer·bioRxiv·Aug 31, 2020
- Identification of small molecule agonists of fetal hemoglobin expression for the treatment of sickle cell disease
Jian-Ping Yang, Rachel Toughiri, … Shane R. Horman·PLoS ONEPeer-reviewed·Nov 6, 2024
- CRISPR-Cas9 interrogation of a putative fetal globin repressor in human erythroid cells.
Jennifer E. Chung, Wendy Magis, … Mark A. DeWitt·PLoS ONEPeer-reviewed·Jan 15, 2019